Cancer Vaccines: Analytical Tool

LONDON, Nov. 6, 2018 /PRNewswire/ -- With the first prophylactic cancer vaccine Gardasil approved in 2006 and therapeutic cancer vaccine Sipuleucel-T (Provenge) approved in 2010, cancer vaccines is a proven hot treatment modality which is now turbocharged with the event of immune-checkpoint inhibitors.

Download the full report: https://www.reportbuyer.com/product/5576159


Cancer Vaccines: Analytical Tool is the most up to date and comprehensive commercial pipeline review and competitive assessment available on this hot and fast moving area in immune-oncology. This unique product is truly the only one of its kind and is designed to give you a competitive edge in your cancer vaccine drug intelligence.

Your Cancer Vaccines: Analytical Tool is based on two decades of proven methodology in serving clients with interest in:
* Target Scouting
* Early & Late Stage Pipeline Analysis
* Biomarker/Companion Diagnostic Analysis (featured below)
* Deal & Alliance Analysis
* Conference surveillance of world leading cancer meetings (featured below)
* Combination Therapy Analysis (featured below)
* Clinical Trial Results Analysis
* Indication Selection & Expansion Analysis
* First-in-Class Analysis
* Drug Repositioning
* Pipeline Analysis by Targeted Pathways
* Instantly generate drug profiles, drug target profiles and company profiles (including Business Development & Licensing contacts)

Analytical Tools transform your computer's desktop into a high capacity workbench within your area of choice. Even before launching this tool you have already eliminated hundreds of hours of work needed to discover, process and piece together the thousands of sources that our team of oncology dedicated and highly experienced contents specialists have done on your behalf.

Your Cancer Vaccines: Analytical Tool covers more than 363 companies plus partners who are today developing 755 cancer vaccine drugs where of 472 are in active development in cancer across 211 different targets. Any data and/or analysis from the Analytical Tool is yours to keep and data/graphs/tables can be easily exported into Excel/PDF and various graphic formats for mixing with your own proprietary information.

Let our expertise work for you
With a simple point and click interface you can navigate the environment of current development, drill down into specific areas such as ongoing combination trials, biomarker analysis, selected scientific abstracts etc. and generate drug profiles, drug target profiles and company profiles (including Business Development & Licensing contacts). Any analysis generated by you is packed with presentation-ready graphs and tables to use in your reports and presentations.

Your key to access development at the world-leading cancer meetings
The Cancer Vaccines: Analytical Tool is continuously updated according to twelve of the world's most influential meetings in oncology (AACR, ASCO, ASGCT, ASH, CIMT, EHA, EORTC-NCI-AACR, ESMO, SITC and BIO (International, Europe and Asia). If you are not able to attend any of the conference(s) in person, this Analytical Tool ensures that you are not missing out on the important take home messages you need to know about.

Run combination therapy analysis like no other
The Cancer Vaccines: Analytical Tool delivers comprehensive combination therapy analysis, allowing you to analyze combination therapies from multiple perspectives; from a single drug to virtually any cross section of oncology drugs of interest.

Unparalleled biomarker surveillance
We also provide an outstanding oncology clinical biomarker surveillance & analysis, highlighting clinical phenotyping and patient stratification in trials. This analysis is based on our monitoring of the presence and usage of more than 1,000 biomarkers across tens of thousands of cancer clinical trials.

Support and inspiration at your finger-tips
You also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.

A tool to grow with and keep you informed
Unlike a static report which just represents a particular snapshot in time, all of the Analytical Tools come with one year of online access to twice-weekly updates in both contents and features, pipeline alerts and online support etc. You can choose to renew your access to these updates and support on a yearly basis or go over to our industry leading full service platform covering all oncology drug development, 1stOncology.

System Requirements
- Browser Application (Supports: Internet Explorer, FireFox, Chrome and Safari))
- Internet access

Download the full report: https://www.reportbuyer.com/product/5576159

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com